￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Sotorasib combined with panitumumab in the treatment of mutant refractory colorectal cancer KRASG12C

2026-02-01 22:25:32

Check Details
Sotorasib 960 mg vs. 240 mg in pretreated KRAS G12C high-grade non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Sotorasib plus panitumumab extends PFS in refractory KRAS G12C+ mCRC

2026-02-01 22:25:32

Check Details
Tepotinib continues to show positive results in METex14-skipped NSCLC

2026-02-01 22:25:32

Check Details
Tepotinib combined with osimertinib may provide a chemotherapy-free option for patients with non-small cell lung cancer after first-line osimertinib treatment

2026-02-01 22:25:32

Check Details
Tepotinib/osimertinib combination induces ORR benefit in EGFR mutated non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Tepotinib and gefitinib show long OS in MET-amplified EGFR+ non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Tepotinib demonstrates durable benefits of high-level methionine MET amplification

2026-02-01 22:25:32

Check Details
Tepotinib shows strong response in lung cancer subgroups during long-term follow-up

2026-02-01 22:25:32

Check Details
Tepotinib launch date in China

2026-02-01 22:25:32

Check Details
Tepotinib PFS

2026-02-01 22:25:32

Check Details
How much does Tepotinib cost in 2023

2026-02-01 22:25:32

Check Details
Category
相关知识